A decade of progress in statistical methodology for clinical trials.
暂无分享,去创建一个
[1] R Simon,et al. Measures of explained variation for survival data. , 1990, Statistics in medicine.
[2] Michael Schemper,et al. The explained variation in proportional hazards regression , 1990 .
[3] J O'Quigley,et al. Continual reassessment method: a practical design for phase 1 clinical trials in cancer. , 1990, Biometrics.
[4] P. Thall,et al. Incorporating historical control data in planning phase II clinical trials. , 1990, Statistics in medicine.
[5] C. E. Davis,et al. Empirical Bayes estimates of subgroup effects in clinical trials. , 1990, Controlled clinical trials.
[6] C. Meinert. Meta-analysis: science or religion? , 1989, Controlled clinical trials.
[7] P. Meier,et al. Choosing covariates in the analysis of clinical trials. , 1989, Controlled clinical trials.
[8] E. Laska,et al. Testing whether an identified treatment is best. , 1989, Biometrics.
[9] J. Overall,et al. The superiority of a drug combination over each of its components. , 1989, Statistics in medicine.
[10] M D Hughes,et al. Practical problems in interim analyses, with particular regard to estimation. , 1989, Controlled clinical trials.
[11] D J Spiegelhalter,et al. Comparison of Bayesian with group sequential methods for monitoring clinical trials. , 1989, Controlled clinical trials.
[12] M. Buyse,et al. Analysis of clinical trial outcomes: some comments on subgroup analyses. , 1989, Controlled clinical trials.
[13] B. Schneider. Analysis of clinical trial outcomes: alternative approaches to subgroup analysis. , 1989, Controlled clinical trials.
[14] N K Aaronson,et al. Quality of life assessment in clinical trials: methodologic issues. , 1989, Controlled clinical trials.
[15] J. Ware. Investigating Therapies of Potentially Great Benefit: ECMO , 1989 .
[16] G. Seeber. On the regression analysis of tumour recurrence rates. , 1989, Statistics in medicine.
[17] A A Tsiatis,et al. A linear rank test for use when the main interest is in differences in cure rates. , 1989, Biometrics.
[18] L. Walløe,et al. Estimation of treatment difference following a sequential clinical trial , 1989 .
[19] Stephen J. Ruberg,et al. Contrasts for Identifying the Minimum Effective Dose , 1989 .
[20] B E Storer,et al. Design and analysis of phase I clinical trials. , 1989, Biometrics.
[21] J. Fleiss,et al. A critique of recent research on the two-treatment crossover design. , 1989, Controlled clinical trials.
[22] Nancy L. Geller,et al. Design of Group Sequential Clinical Trials with Multiple Endpoints , 1989 .
[23] J. Boissel,et al. Considerations for the meta-analysis of randomized clinical trials. Summary of a panel discussion. , 1989, Controlled clinical trials.
[24] T R Fleming,et al. Symmetric group sequential test designs. , 1989, Biometrics.
[25] P. Bauer,et al. Multiple Test Procedures in Clinical Dose Finding Studies , 1989 .
[26] D L DeMets,et al. Changing frequency of interim analysis in sequential monitoring. , 1989, Biometrics.
[27] R. Gelber,et al. A quality-of-life-oriented endpoint for comparing therapies. , 1989, Biometrics.
[28] R B Davis,et al. Exponential survival trees. , 1989, Statistics in medicine.
[29] R. Frankowski,et al. Effect of unequal censoring on the size and power of the logrank and Wilcoxon types of tests for survival data. , 1989, Statistics in medicine.
[30] O. Aalen. A linear regression model for the analysis of life times. , 1989, Statistics in medicine.
[31] Christopher Jennison,et al. Interim analyses: the repeated confidence interval approach , 1989 .
[32] D. Altman,et al. Bootstrap investigation of the stability of a Cox regression model. , 1989, Statistics in medicine.
[33] D R Bristol,et al. Sample sizes for constructing confidence intervals and testing hypotheses. , 1989, Statistics in medicine.
[34] Shih Wj. Prediction approaches to sequentially searching for an optimal dose. , 1989 .
[35] D. Oakes,et al. Bivariate survival models induced by frailties , 1989 .
[36] M S Pepe,et al. Weighted Kaplan-Meier statistics: a class of distance tests for censored survival data. , 1989, Biometrics.
[37] D. Bristol. Designing clinical trials for two-sided multiple comparisons with a control. , 1989, Controlled clinical trials.
[38] K Kim,et al. Point estimation following group sequential tests. , 1989, Biometrics.
[39] S. Goodman. Meta-analysis and evidence. , 1989, Controlled clinical trials.
[40] Thomas A. Louis,et al. An Assessment of Publication Bias Using a Sample of Published Clinical Trials , 1989 .
[41] H. Wieand,et al. The bias of the sample proportion following a group sequential phase II clinical trial. , 1989, Statistics in medicine.
[42] A. Gould,et al. The analysis of titration studies in phase III clinical trials. , 1989, Statistics in medicine.
[43] R. Simon,et al. Flexible regression models with cubic splines. , 1989, Statistics in medicine.
[44] M R Segal,et al. A comparison of estimated proportional hazards models and regression trees. , 1989, Statistics in medicine.
[45] A A Tsiatis,et al. The impact that group sequential tests would have made on ECOG clinical trials. , 1989, Statistics in medicine.
[46] R. Prentice. Surrogate endpoints in clinical trials: definition and operational criteria. , 1989, Statistics in medicine.
[47] D. Seigel,et al. Surrogate endpoints in clinical trials: ophthalmologic disorders. , 1989, Statistics in medicine.
[48] J. Wittes,et al. Surrogate endpoints in clinical trials: cardiovascular diseases. , 1989, Statistics in medicine.
[49] J. Herson. The use of surrogate endpoints in clinical trials (an introduction to a series of four papers) , 1989 .
[50] S J Senn,et al. Covariate imbalance and random allocation in clinical trials. , 1989, Statistics in medicine.
[51] S. Ellenberg,et al. Surrogate endpoints in clinical trials: cancer. , 1989, Statistics in medicine.
[52] R. Simon,et al. Optimal two-stage designs for phase II clinical trials. , 1989, Controlled clinical trials.
[53] F. Rockhold,et al. Monitoring versus interim analysis of clinical trials: a perspective from the pharmaceutical industry. , 1989, Controlled clinical trials.
[54] R Brookmeyer,et al. Modelling paired survival data with covariates. , 1989, Biometrics.
[55] M. Chang,et al. Confidence intervals for a normal mean following a group sequential test. , 1989, Biometrics.
[56] Choi Sc,et al. Monitoring clinical trials based on predictive probability of significance. , 1989 .
[57] J. Crowley,et al. A general class of nonparametric tests for survival analysis. , 1989, Biometrics.
[58] T C Chalmers,et al. A comparison of statistical methods for combining event rates from clinical trials. , 1989, Statistics in medicine.
[59] J. Wittes,et al. Factorial designs in clinical trials: the effects of non-compliance and subadditivity. , 1989, Statistics in medicine.
[60] L J Emrich,et al. Required duration and power determinations for historically controlled studies of survival times. , 1989, Statistics in medicine.
[61] J. Friedman,et al. FLEXIBLE PARSIMONIOUS SMOOTHING AND ADDITIVE MODELING , 1989 .
[62] C. Begg,et al. Publication bias and dissemination of clinical research. , 1989, Journal of the National Cancer Institute.
[63] Nitin R. Patel,et al. Importance Sampling for Estimating Exact Probabilities in Permutational Inference , 1988 .
[64] J P Matts,et al. Randomization in clinical trials: conclusions and recommendations. , 1988, Controlled clinical trials.
[65] S. Pocock,et al. Stopping rules and estimation problems in clinical trials. , 1988, Statistics in medicine.
[66] O. Aalen,et al. Heterogeneity in survival analysis. , 1988, Statistics in medicine.
[67] F. Harrell,et al. Regression models in clinical studies: determining relationships between predictors and response. , 1988, Journal of the National Cancer Institute.
[68] L S Freedman,et al. Comparing the effects of different durations of the same therapy. , 1988, Statistics in medicine.
[69] R. Simon,et al. Planning and monitoring of equivalence studies. , 1988, Biometrics.
[70] L A Kalish,et al. Efficiency of balanced treatment allocation for survival analysis. , 1988, Biometrics.
[71] Stephen G. Eick,et al. Gittins procedures for bandits with delayed responses , 1988 .
[72] D R Bristol,et al. A one-sided interim analysis with binary outcomes. , 1988, Controlled clinical trials.
[73] John T. Kent,et al. Measures of dependence for censored survival data , 1988 .
[74] L. J. Wei,et al. Exact two-sample permutation tests based on the randomized play-the-winner rule , 1988 .
[75] R J Sylvester,et al. A bayesian approach to the design of phase II clinical trials. , 1988, Biometrics.
[76] R. Sugden,et al. Sampling and Assignment Mechanisms in Experiments, Surveys and Observational , 1988 .
[77] J. N. S. Matthews,et al. Recent Developments in Crossover Designs , 1988 .
[78] D Clayton,et al. The analysis of event history data: a review of progress and outstanding problems. , 1988, Statistics in medicine.
[79] D. N. Geary. Sequential testing in clinical trials with repeated measurements , 1988 .
[80] Richard Simon,et al. Two-stage selection and testing designs for comparative clinical trials , 1988 .
[81] P. Andersen,et al. Multistate models in survival analysis: a study of nephropathy and mortality in diabetes. , 1988, Statistics in medicine.
[82] Nitin R. Patel,et al. Constructing exact significance tests with restricted randomization rules , 1988 .
[83] D J Schaid,et al. A design for phase II testing of anticancer agents within a phase III clinical trial. , 1988, Controlled clinical trials.
[84] B. Efron. Logistic Regression, Survival Analysis, and the Kaplan-Meier Curve , 1988 .
[85] M. A. Moussa. Planning the size of survival time clinical trials with allowance for stratification. , 1988, Statistics in medicine.
[86] C. Begg,et al. Publication bias : a problem in interpreting medical data , 1988 .
[87] P. Thall,et al. Optimal two-stage designs for clinical trials with binary response. , 1988, Statistics in medicine.
[88] Olivier Guilbaud,et al. Exact Kolmogorov-Type Tests for Left-Truncated and/or Right-Censored Data , 1988 .
[89] E. Lakatos,et al. Sample sizes based on the log-rank statistic in complex clinical trials. , 1988, Biometrics.
[90] M C Wu,et al. Sample size for comparison of changes in the presence of right censoring caused by death, withdrawal, and staggered entry. , 1988, Controlled clinical trials.
[91] Elja Arjas,et al. A Graphical Method for Assessing Goodness of Fit in Cox's Proportional Hazards Model , 1988 .
[92] KyungMann Kim,et al. Improved approximation for estimation following closed sequential tests , 1988 .
[93] M. H. Gail,et al. Tests for no treatment e?ect in randomized clinical trials , 1988 .
[94] J C Bailar,et al. Guidelines for statistical reporting in articles for medical journals. Amplifications and explanations. , 1988, Annals of internal medicine.
[95] Joel B. Greenhouse,et al. Selection Models and the File Drawer Problem , 1988 .
[96] K. Dickersin,et al. Publication bias and clinical trials. , 1987, Controlled clinical trials.
[97] Sylvan Wallenstein,et al. The Power of the Mantel—Haenszel Test , 1987 .
[98] A. Gross,et al. Sample size determination in clinical trials with an emphasis on exponentially distributed responses. , 1987, Biometrics.
[99] T. Morgan. Nonparametric estimation of duration of accrual and total study length for clinical trials. , 1987, Biometrics.
[100] K Kim,et al. Confidence intervals following group sequential tests in clinical trials. , 1987, Biometrics.
[101] T M Therneau,et al. Designs for group sequential phase II clinical trials. , 1987, Biometrics.
[102] Nitin R. Patel,et al. Computing Distributions for Exact Logistic Regression , 1987 .
[103] R. Simon,et al. How large should a phase II trial of a new drug be? , 1987, Cancer treatment reports.
[104] Allan R. Wilks,et al. Dynamic Graphics for Data Analysis , 1987 .
[105] J. Jais,et al. A transient state model for analysing ventilatory status in a randomized clinical trial. , 1987, Statistics in medicine.
[106] M. Schumacher,et al. The impact of heterogeneity on the comparison of survival times. , 1987, Statistics in medicine.
[107] T C Chalmers,et al. Meta-analysis of clinical trials as a scientific discipline. II: Replicate variability and comparison of studies that agree and disagree. , 1987, Statistics in medicine.
[108] R G Newcombe,et al. Towards a reduction in publication bias. , 1987, British medical journal.
[109] J M Nam,et al. A simple approximation for calculating sample sizes for detecting linear trend in proportions. , 1987, Biometrics.
[110] J Halpern,et al. Designing clinical trials with arbitrary specification of survival functions and for the log rank or generalized Wilcoxon test. , 1987, Controlled clinical trials.
[111] F. T. Wright,et al. Comparison of Several Treatments with a Control Using Multiple Contrasts , 1987 .
[112] S. Snapinn,et al. Evaluating the efficacy of a combination therapy. , 1987, Statistics in medicine.
[113] N L Geller,et al. The analysis of multiple endpoints in clinical trials. , 1987, Biometrics.
[114] E. Korn,et al. Effective sample sizes for confidence intervals for survival probabilities. , 1987, Statistics in medicine.
[115] S. Pocock,et al. Statistical problems in the reporting of clinical trials. A survey of three medical journals. , 1987, The New England journal of medicine.
[116] W. H. Carter,et al. Sample sizes for cancer therapy survival studies based on response surface methods , 1987 .
[117] F. Hsieh. A simple method of sample size calculation for unequal-sample-size designs that use the logrank or t-test. , 1987, Statistics in medicine.
[118] M. Buyse,et al. Issues of efficiency in combining proportions of deaths from several clinical trials. , 1987, Statistics in medicine.
[119] C. Chuang. The analysis of a titration study. , 1987, Statistics in medicine.
[120] J Halpern,et al. Cure rate models: power of the logrank and generalized Wilcoxon tests. , 1987, Statistics in medicine.
[121] T. Morgan,et al. Optimal restricted two-stage designs. , 1987, Controlled clinical trials.
[122] G. E. Noether,et al. Sample Size Determination for Some Common Nonparametric Tests , 1987 .
[123] R. Gill,et al. A simple test of the proportional hazards assumption , 1987 .
[124] David A. Schoenfeld,et al. A modified log rank test for highly stratified data , 1987 .
[125] A. Tsiatis,et al. Approximately optimal one-parameter boundaries for group sequential trials. , 1987, Biometrics.
[126] David P. Harrington,et al. Supremum versions of the log-rank and generalized wilcoxon statistics , 1987 .
[127] D. Duffy,et al. Confidence Intervals for a Binomial Parameter Based on Multistage Tests , 1987 .
[128] Christopher Jennison,et al. Efficient group sequential tests with unpredictable group sizes , 1987 .
[129] R. Sposto,et al. Use of unequal allocation in survival trials. , 1987, Statistics in medicine.
[130] David L. DeMets,et al. Design and analysis of group sequential tests based on the type I error spending rate function , 1987 .
[131] Thomas R. Fleming,et al. A paired prentice-Wilcoxon test for censored paired data , 1987 .
[132] P K Andersen,et al. Conditional power calculations as an aid in the decision whether to continue a clinical trial. , 1987, Controlled clinical trials.
[133] R. Connor. Sample size for testing differences in proportions for the paired-sample design. , 1987, Biometrics.
[134] N L Geller,et al. Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners. , 1987, Biometrics.
[135] Antonio Ciampi,et al. Extended hazard regression for censored survival data with covariates : a spline approximation for the baseline hazard function , 1987 .
[136] T. Therneau,et al. A two-stage design for randomized trials with binary outcomes. , 1987, Controlled clinical trials.
[137] T. Chalmers,et al. Meta-analyses of randomized controlled trials. , 1987, The New England journal of medicine.
[138] John Whitehead,et al. On the bias of maximum likelihood estimation following a sequential test , 1986 .
[139] Robert M. Elashoff,et al. Effect of Categorizing a Continuous Covariate on the Comparison of Survival Time , 1986 .
[140] J. Fleiss,et al. Analysis of data from multiclinic trials. , 1986, Controlled clinical trials.
[141] Morgan Tm,et al. Omitting covariates from the proportional hazards model. , 1986 .
[142] R Kay,et al. A Markov model for analysing cancer markers and disease states in survival studies. , 1986, Biometrics.
[143] D. Finkelstein,et al. A proportional hazards model for interval-censored failure time data. , 1986, Biometrics.
[144] R. Elashoff,et al. Simultaneous non-parametric confidence intervals for survival probabilities from censored data. , 1986, Statistics in medicine.
[145] J. Whitehead. Supplementary analysis at the conclusion of a sequential clinical trial. , 1986, Biometrics.
[146] J M Lachin,et al. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. , 1986, Biometrics.
[147] R. Marshall,et al. Partitioning methods for classification and decision making in medicine. , 1986, Statistics in medicine.
[148] A. Willan,et al. Carryover and the two-period crossover clinical trial. , 1986, Biometrics.
[149] G. Stein,et al. The determination of practically useful doses of new drugs: some methodological considerations. , 1986, Statistics in medicine.
[150] S K Carter,et al. Calibrated phase II clinical trials in oncology. , 1986, Statistics in medicine.
[151] J Whitehead,et al. Sample sizes for phase II and phase III clinical trials: an integrated approach. , 1986, Statistics in medicine.
[152] R. Simon,et al. Confidence intervals for reporting results of clinical trials. , 1986, Annals of internal medicine.
[153] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[154] E. Lakatos,et al. Sample size determination in clinical trials with time-dependent rates of losses and noncompliance. , 1986, Controlled clinical trials.
[155] John O'Quigley,et al. On D. Schoenfeld's approach for testing the proportional hazards assumption , 1986 .
[156] D. Oakes,et al. Semiparametric inference in a model for association in bivanate survival data , 1986 .
[157] P. Hougaard. Survival models for heterogeneous populations derived from stable distributions , 1986 .
[158] Gregg E. Dinse,et al. A note on semi-Markov models for partially censored data , 1986 .
[159] P Y Chi,et al. A clinical trial with an interim analysis. , 1986, Statistics in medicine.
[160] A. F. Smith,et al. Bayesian Methods in Practice: Experiences in the Pharmaceutical Industry , 1986 .
[161] E. Korn. Censoring distributions as a measure of follow-up in survival analysis. , 1986, Statistics in medicine.
[162] R. Makuch,et al. Some issues in the design and interpretation of 'negative' clinical studies. , 1986, Archives of internal medicine.
[163] B W Brown,et al. Sequential treatment allocation procedures in clinical trials--with particular attention to the analysis of results for the biased coin design. , 1986, Statistics in medicine.
[164] G. Guyatt,et al. Determining optimal therapy--randomized trials in individual patients. , 1986, The New England journal of medicine.
[165] M. Gardner,et al. Confidence intervals rather than P values: estimation rather than hypothesis testing. , 1986, British medical journal.
[166] E. Korn. Sample size tables for bounding small proportions. , 1986, Biometrics.
[167] R. T. Smythe,et al. $K$-Treatment Comparisons with Restricted Randomization Rules in Clinical Trials , 1986 .
[168] P. O'Brien,et al. Confidence intervals following group sequential tests. , 1986, Controlled clinical trials.
[169] K K Lan,et al. Monitoring boundaries for adverse effects in long-term clinical trials. , 1986, Controlled clinical trials.
[170] D. Spiegelhalter,et al. Monitoring clinical trials: conditional or predictive power? , 1986, Controlled clinical trials.
[171] Robert Tibshirani,et al. Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy , 1986 .
[172] R. Wolfe,et al. A semiparametric model for regression analysis of interval-censored failure time data. , 1985, Biometrics.
[173] M H Gail,et al. Use of logrank tests and group sequential methods at fixed calendar times. , 1985, Biometrics.
[174] E. DeLong,et al. Sensitivity and specificity of a monitoring test. , 1985, Biometrics.
[175] Cyrus R. Mehta,et al. Computing an Exact Confidence Interval for the Common Odds Ratio in Several 2×2 Contingency Tables , 1985 .
[176] Christopher Jennison,et al. Repeated confidence intervals for the median survival time , 1985 .
[177] Sung C. Choi,et al. Early decision in clinical trials when the treatment differences are small. Experience of a controlled trial in head trauma. , 1985, Controlled clinical trials.
[178] S S Ellenberg,et al. Randomized phase II clinical trials. , 1985, Cancer treatment reports.
[179] Mounir Mesbah,et al. A Global Goodness‐Of‐Fit Statistic for the Proportional Hazards Model , 1985 .
[180] F. Harrell,et al. Regression models for prognostic prediction: advantages, problems, and suggested solutions. , 1985, Cancer treatment reports.
[181] R Brookmeyer,et al. An application of Bayesian analysis to medical follow-up data. , 1985, Statistics in medicine.
[182] S S Ellenberg,et al. An efficient design for phase III studies of combination chemotherapies. , 1985, Cancer treatment reports.
[183] D. Berry,et al. Interim analyses in clinical trials: classical vs. Bayesian approaches. , 1985, Statistics in medicine.
[184] Brown Bw,et al. Confidence limits for probability of response in multistage phase II clinical trials. , 1985 .
[185] B. Silverman,et al. Some Aspects of the Spline Smoothing Approach to Non‐Parametric Regression Curve Fitting , 1985 .
[186] J. Anderson,et al. Asymptotically efficient two-step estimators of the hazards ratio for follow-up studies and survival data. , 1985, Biometrics.
[187] D. Stablein,et al. A two-sample test sensitive to crossing hazards in uncensored and singly censored data. , 1985, Biometrics.
[188] Anastasios A. Tsiatis,et al. Group sequential tests with censored survival data adjusting for covariates , 1985 .
[189] D P Byar,et al. Assessing apparent treatment--covariate interactions in randomized clinical trials. , 1985, Statistics in medicine.
[190] Samy Suissa,et al. Exact Unconditional Sample Sizes for the 2 Times 2 Binomial Trial , 1985 .
[191] M Palta,et al. Investigating maximum power losses in survival studies with nonstratified randomization. , 1985, Biometrics.
[192] Linda June Davis,et al. Generalization of the Mantel―Haenszel estimator to nonconstant odds ratios , 1985 .
[193] N. Birkett,et al. Adaptive allocation in randomized controlled trials. , 1985, Controlled clinical trials.
[194] J Whitehead,et al. Designing phase II studies in the context of a programme of clinical research. , 1985, Biometrics.
[195] M. Gail,et al. Testing for qualitative interactions between treatment effects and patient subsets. , 1985, Biometrics.
[196] P Armitage,et al. Repeated significance tests for clinical trials with a fixed number of patients and variable follow-up. , 1985, Biometrics.
[197] W. Willett,et al. The 2 × 2 factorial design: Its application to a randomized trial of aspirin and U.S. physicians , 1985 .
[198] Nancy Reid,et al. Influence functions for proportional hazards regression , 1985 .
[199] C B Begg,et al. Treatment allocation methods in clinical trials: a review. , 1985, Statistics in medicine.
[200] J. A. Bather,et al. On the Allocation of Treatments in Sequential Medical Trials , 1985 .
[201] I. Chalmers. Proposal to outlaw the term “negative trial” , 1985 .
[202] R. Peto,et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.
[203] D. Clayton,et al. Multivariate generalizations of the proportional hazards model , 1985 .
[204] J W Tukey,et al. Testing the statistical certainty of a response to increasing doses of a drug. , 1985, Biometrics.
[205] J. Crowley,et al. A Diagnostic for Cox Regression and General Conditional Likelihoods , 1985 .
[206] David L. DeMets,et al. Statistical aspects of early termination in the beta-blocker heart attack trial , 1984 .
[207] S W Lagakos,et al. Properties of proportional-hazards score tests under misspecified regression models. , 1984, Biometrics.
[208] S. Duffy. Asymptotic and Exact Power for the McNemar Test and its Analogue with R Controls per Case , 1984 .
[209] B Rosner,et al. Multivariate methods in ophthalmology with application to other paired-data situations. , 1984, Biometrics.
[210] P. O'Brien. Procedures for comparing samples with multiple endpoints. , 1984, Biometrics.
[211] L Edler,et al. A two-sample censored-data rank test for acceleration. , 1984, Biometrics.
[212] M. Gail,et al. Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariates , 1984 .
[213] T R Fleming,et al. Designs for group sequential tests. , 1984, Controlled clinical trials.
[214] P. Macaskill,et al. Stopping rules for clinical trials incorporating clinical opinion. , 1984, Biometrics.
[215] A A Tsiatis,et al. Exact significance testing to establish treatment equivalence with ordered categorical data. , 1984, Biometrics.
[216] R. Dennis Cook,et al. Cross-Validation of Regression Models , 1984 .
[217] B S Pasternack,et al. A note on data monitoring, incomplete data and curtailed testing. , 1984, Controlled Clinical Trials.
[218] D P Byar,et al. A comparison of reflected versus test-based confidence intervals for the median survival time, based on censored data. , 1984, Biometrics.
[219] D. Tritchler. An Algorithm for Exact Logistic Regression , 1984 .
[220] A A Tsiatis,et al. Exact confidence intervals following a group sequential test. , 1984, Biometrics.
[221] D. E. Matthews. Some observations on semi‐markov models for partially censored data , 1984 .
[222] L. J. Wei,et al. Testing Goodness of Fit for Proportional Hazards Model with Censored Observations , 1984 .
[223] A Donner,et al. Approaches to sample size estimation in the design of clinical trials--a review. , 1984, Statistics in medicine.
[224] Richard L. Smith. Sequential Treatment Allocation Using Biased Coin Designs , 1984 .
[225] R Kay,et al. Multistate Survival Analysis: An Application in Breast Cancer , 1984, Methods of Information in Medicine.
[226] T. Louis. Estimating a population of parameter values using Bayes and empirical Bayes methods , 1984 .
[227] N. Lange,et al. Approximate case influence for the proportional hazards regression model with censored data. , 1984, Biometrics.
[228] W. Blackwelder,et al. Sample size graphs for "proving the null hypothesis". , 1984, Controlled clinical trials.
[229] Eric V. Slud,et al. Sequential Linear Rank Tests for Two-Sample Censored Survival Data , 1984 .
[230] C. Le,et al. Confidence estimation and the size of a clinical trial. , 1984, Controlled clinical trials.
[231] H. Thaler. Nonparametric Estimation of the Hazard Ratio , 1984 .
[232] C. Begg,et al. Treatment allocation for nonlinear models in clinical trials: the logistic model. , 1984, Biometrics.
[233] N. Nagelkerke,et al. A simple test for goodness-of-fit of Cox''s proportional hazards model Biometrics 40 , 1984 .
[234] A. Willan,et al. Clinical trials as diagnostic tests. , 1984, Controlled clinical trials.
[235] A I Goldman,et al. Survivorship analysis when cure is a possibility: a Monte Carlo study. , 1984, Statistics in medicine.
[236] Philip Hougaard,et al. Life table methods for heterogeneous populations: Distributions describing the heterogeneity , 1984 .
[237] Mark Brown,et al. On the choice of variance for the log rank test , 1984 .
[238] Y. J. Lee. Quick and simple approximation of sample sizes for comparing two independent binomial distributions: different-sample-size case. , 1984, Biometrics.
[239] D. Harrington,et al. Considerations for monitoring and evaluating treatment effects in clinical trials. , 1984, Controlled clinical trials.
[240] Joseph G. Voelkel,et al. Nonparametric Inference for a Class of Semi-Markov Processes with Censored Observations , 1984 .
[241] B. Turnbull,et al. Repeated confidence intervals for group sequential clinical trials. , 1984, Controlled clinical trials.
[242] P. Canner. Further aspects of data analysis , 1983 .
[243] P. Canner. The Coronary Drug Project. Monitoring of the data for evidence of adverse or beneficial treatment effects. , 1983, Controlled clinical trials.
[244] R. G. Miller,et al. What price Kaplan-Meier? , 1983, Biometrics.
[245] Eric V. Slud,et al. Dependent competing risks and summary survival curves , 1983 .
[246] K. K. Lan,et al. Discrete sequential boundaries for clinical trials , 1983 .
[247] J R Anderson,et al. Analysis of survival by tumor response. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[248] P M Fayers,et al. Measuring and analysing quality of life in cancer clinical trials: a review. , 1983, Statistics in medicine.
[249] R Brookmeyer,et al. Prediction intervals for survival data. , 1983, Statistics in medicine.
[250] J. Bolognese,et al. A Monte Carlo comparison of three up-and-down designs for dose ranging. , 1983, Controlled clinical trials.
[251] J. Dambrosia,et al. Early stopping for sequential restricted tests of binomial distributions. , 1983, Biometrics.
[252] Thomas Sellke,et al. Sequential analysis of the proportional hazards model , 1983 .
[253] D. Schoenfeld,et al. Sample-size formula for the proportional-hazards regression model. , 1983, Biometrics.
[254] Nitin R. Patel,et al. A Network Algorithm for Performing Fisher's Exact Test in r × c Contingency Tables , 1983 .
[255] M. Symons,et al. Sample size and duration for cohort studies of survival time with covariables. , 1983, Biometrics.
[256] A Morabito,et al. Prognostic factors and risk groups: some results given by using an algorithm suitable for censored survival data. , 1983, Statistics in medicine.
[257] N. Mantel,et al. Stratified analysis of multivariate clinical data: application of a Mantel-Haenszel approach. , 1983, Statistics in medicine.
[258] F. Y. Hsieh,et al. Some test statistics for use in multistate survival analysis , 1983 .
[259] R. Tibshirani,et al. A family of proportional- and additive-hazards models for survival data. , 1983, Biometrics.
[260] R. McHugh,et al. Post-stratification in the randomized clinical trial. , 1983, Biometrics.
[261] J Whitehead,et al. Group sequential clinical trials with triangular continuation regions. , 1983, Biometrics.
[262] D. Spiegelhalter,et al. The Assessment of the Subjective Opinion and its Use in Relation to Stopping Rules for Clinical Trials , 1983 .
[263] M. Zelen. Guidelines for publishing papers on cancer clinical trials: responsibilities of editors and authors. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[264] Christopher Jennison,et al. Confidence Intervals for a Binomial Parameter Following a Multistage Test With Application to MIL-STD 105D and Medical Trials , 1983 .
[265] D L DeMets,et al. An aid to data monitoring in long-term clinical trials. , 1982, Controlled clinical trials.
[266] Rupert G. Miller,et al. Regression with censored data , 1982 .
[267] Anastasios A. Tsiatis,et al. Repeated Significance Testing for a General Class of Statistics Used in Censored Survival Analysis , 1982 .
[268] D. Harrington. A class of rank test procedures for censored survival data , 1982 .
[269] Eric V. Slud,et al. Two-Sample Repeated Significance Tests Based on the Modified Wilcoxon Statistic , 1982 .
[270] N. Mantel. An uncontrolled clinical trial--treatment response or spontaneous improvement? , 1982, Controlled clinical trials.
[271] David L. DeMets,et al. Asymmetric group sequential boundaries for monitoring clinical trials , 1982 .
[272] M. Gail,et al. Monitoring rules for stopping accrual in comparative survival studies. , 1982, Controlled clinical trials.
[273] V. Farewell,et al. The use of mixture models for the analysis of survival data with long-term survivors. , 1982, Biometrics.
[274] R. Simon,et al. Patient subsets and variation in therapeutic efficacy. , 1982, British journal of clinical pharmacology.
[275] Jack Cuzick,et al. Rank tests for association with right censored data , 1982 .
[276] D. Oakes. A Model for Association in Bivariate Survival Data , 1982 .
[277] Frederick Mosteller,et al. Reporting on methods in clinical trials. , 1982, The New England journal of medicine.
[278] J R Anderson,et al. Approximate confidence intervals for probabilities of survival and quantiles in life-table analysis. , 1982, Biometrics.
[279] B W Brown,et al. KSTAGE: an interactive computer program for designing phase II clinical trials using predictive probability. , 1982, Computers and biomedical research, an international journal.
[280] Ron Brookmeyer,et al. A k-Sample Median Test for Censored Data , 1982 .
[281] R. Simon,et al. Randomized clinical trials and research strategy. , 1982, Cancer treatment reports.
[282] A. Atkinson. Optimum biased coin designs for sequential clinical trials with prognostic factors , 1982 .
[283] A. Lawrence Gould,et al. Group sequential methods for clinical trials allowing early acceptance of Ho and incorporating costs , 1982 .
[284] R. Madsen,et al. P values for tests using a repeated significance test design , 1982 .
[285] David A. Schoenfeld,et al. Partial residuals for the proportional hazards regression model , 1982 .
[286] S J Pocock,et al. Interim analyses for randomized clinical trials: the group sequential approach. , 1982, Biometrics.
[287] Per Kragh Andersen,et al. Testing Goodness of Fit of Cox's Regression and Life Model , 1982 .
[288] John D. Emerson,et al. Nonparametwic Confidence Intervals for the Median in the Presence of Right CensoriIlg , 1982 .
[289] D. Schoenfeld,et al. Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. , 1982, Biometrics.
[290] D. DeMets,et al. Early stopping in the two-sample problem for bounded random variables. , 1982, Controlled clinical trials.
[291] T. Chalmers. Discussion: Combination of Data from Randomized Control Trials , 1982 .
[292] Ron Brookmeyer,et al. A Confidence Interval for the Median Survival Time , 1982 .
[293] T R Fleming,et al. One-sample multiple testing procedure for phase II clinical trials. , 1982, Biometrics.
[294] Marcello Pagano,et al. An Algorithm for Finding the Exact Significance Levels of r × c Contingency Tables , 1981 .
[295] Nancy Reid,et al. Estimating the median survival time , 1981 .
[296] R. Latta,et al. A Monte Carlo Study of Some Two-Sample Rank Tests with Censored Data , 1981 .
[297] L. Bernstein,et al. Estimation of the proportional hazard in two-treatment-group clinical trials. , 1981, Biometrics.
[298] Robert F. Woolson,et al. Rank tests for censored randomized block designs , 1981 .
[299] Thomas A. Louis,et al. Nonparametric analysis of an accelerated failure time model , 1981 .
[300] J. Bather. Randomized Allocation of Treatments in Sequential Experiments , 1981 .
[301] W. H. Carter,et al. Analysis of survival data with nonproportional hazard functions. , 1981, Controlled clinical trials.
[302] J. Lachin. Introduction to sample size determination and power analysis for clinical trials. , 1981, Controlled clinical trials.
[303] Bradley Efron,et al. Censored Data and the Bootstrap , 1981 .
[304] W C Blackwelder,et al. "Proving the null hypothesis" in clinical trials. , 1981, Controlled clinical trials.
[305] T C Chalmers,et al. A method for assessing the quality of a randomized control trial. , 1981, Controlled clinical trials.
[306] D. Schoenfeld. The asymptotic properties of nonparametric tests for comparing survival distributions , 1981 .
[307] Anastasios A. Tsiatis,et al. The asymptotic joint distribution of the efficient scores test for the proportional hazards model calculated over time , 1981 .
[308] Stephen W. Lagakos,et al. The graphical evaluation of explanatory variables in proportional hazard regression models , 1981 .
[309] M H Gail,et al. Evaluating serial cancer marker studies in patients at risk of recurrent disease. , 1981, Biometrics.
[310] J. Lachin. Sequential clinical trials for normal variates using interval composite hypotheses. , 1981, Biometrics.
[311] R. Tarone,et al. On the distribution of the maximum of the longrank statistic and the modified Wilcoxon statistic , 1981 .
[312] David P. Harrington,et al. Modified Kolmogorov-Smirnov Test Procedures with Application to Arbitrarily Right-Censored Data , 1980 .
[313] James H. Ware,et al. Conditional Distribution-Free Tests for the Two-Sample Problem in the Presence of Right Censoring , 1980 .
[314] D. DeMets,et al. Sample sizes for long-term medical trial with time-dependent dropout and event rates. , 1980, Controlled clinical trials.
[315] D. Stablein,et al. Survival analysis of drug combinations using a hazards model with time-dependent covariates. , 1980, Biometrics.
[316] L. J. Wei. A Generalized Gehan and Gilbert Test for Paired Observations that are Subject to Arbitrary Right Censorship , 1980 .
[317] K. Glazebrook. On Randomized Dynamic Allocation Indices for the Sequential Design of Experiments , 1980 .
[318] J. Anderson,et al. Smooth Estimates for the Hazard Function , 1980 .
[319] H K Ury,et al. On approximate sample sizes for comparing two independent proportions with the use of Yates' correction. , 1980, Biometrics.
[320] F. Mosteller,et al. Reporting standards and research strategies for controlled trials , 1980 .
[321] A. Ciampi,et al. Null results in clinical trials: the need for a decision-theory approach. , 1980, British Journal of Cancer.
[322] C B Begg,et al. A treatment allocation procedure for sequential clinical trials. , 1980, Biometrics.
[323] B. W. Brown. The crossover experiment for clinical trials. , 1980, Biometrics.
[324] J. Herson,et al. Predictive probability early termination plans for phase II clinical trials. , 1979, Biometrics.
[325] A. Spriet,et al. When can 'non significantly different' treatments be considered as 'equivalent'? , 1979, British Journal of Clinical Pharmacology.
[326] R. Simon,et al. Restricted randomization designs in clinical trials. , 1979, Biometrics.
[327] S. Lagakos,et al. Sample size and power determination for stratified clinical trials , 1978 .
[328] R. Makuch,et al. Sample size requirements for evaluating a conservative therapy. , 1978, Cancer treatment reports.
[329] R. Simon,et al. Adaptive treatment assignment methods and clinical trials. , 1977, Biometrics.
[330] S. Pocock. Group sequential methods in the design and analysis of clinical trials , 1977 .
[331] S. Pocock,et al. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. , 1975, Biometrics.
[332] D R Taves,et al. Minimization: A new method of assigning patients to treatment and control groups , 1974, Clinical pharmacology and therapeutics.
[333] P F Thall,et al. A two-stage design for choosing among several experimental treatments and a control in clinical trials. , 1989, Biometrics.
[334] D. Berry. Monitoring accumulating data in a clinical trial. , 1989, Biometrics.
[335] R Simon,et al. Sample size considerations for studies comparing survival curves using historical controls. , 1988, Journal of clinical epidemiology.
[336] J F Lawless,et al. Regression and recursive partition strategies in the analysis of medical survival data. , 1988, Journal of clinical epidemiology.
[337] J. V. Reed,et al. Practical experience of minimisation in clinical trials , 1988 .
[338] D A Berry,et al. One-sided sequential stopping boundaries for clinical trials: a decision-theoretic approach. , 1988, Biometrics.
[339] B. Efron. The jackknife, the bootstrap, and other resampling plans , 1987 .
[340] Donald A. Berry,et al. Interim analysis in clinical trials; the role of the likelihood principle , 1987 .
[341] R. Simes,et al. Confronting publication bias: a cohort design for meta-analysis. , 1987, Statistics in medicine.
[342] R. Elashoff,et al. Effect of covariate measurement error in randomized clinical trials. , 1987, Statistics in Medicine.
[343] R. Simon. Overviews of randomized clinical trials. , 1987, Cancer treatment reports.
[344] T. Morgan,et al. Effect of censoring on adjusting for covariates in comparison of survival times , 1986 .
[345] Robert H. Bartlett,et al. Randomized play the winner clinical trials , 1986 .
[346] M. Haber,et al. An exact unconditional test for the 2 x 2 comparative trial. , 1986, Psychological bulletin.
[347] M S Kochar,et al. The peer review of manuscripts--in need for improvement. , 1986, Journal of chronic diseases.
[348] Cyrus R. Mehta,et al. A hybrid algorithm for fisher's exact test in unordered rxc contingency tables , 1986 .
[349] D. Spiegelhalter,et al. A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. , 1986, Statistics in medicine.
[350] S. Piantadosi,et al. Factorial designs for randomized clinical trials. , 1985, Cancer treatment reports.
[351] Alan B. Forsythe,et al. Post-hoc selection of covariates in randomized experiments , 1985 .
[352] M. Palta,et al. Consideration of covariates and stratification in sample size determination for survival time studies. , 1985, Journal of chronic diseases.
[353] Samy Suissa,et al. Exact unconditional sample sizes for the 2×2 binomial trial , 1985 .
[354] C B Begg,et al. A measure to aid in the interpretation of published clinical trials. , 1985, Statistics in medicine.
[355] A. Ciampi,et al. A general model for testing the proportional hazards and the accelerated failure time hypotheses in the analysis of censored survival data with covariates , 1985 .
[356] Changbao Wu,et al. Optimality of random allocation design for the control of accidental bias in sequential experiments , 1985 .
[357] S. George. Statistics in medical journals: a survey of current policies and proposals for editors. , 1985, Medical and pediatric oncology.
[358] H. Sather,et al. Determining the duration of comparative clinical trials while allowing for cure. , 1985, Journal of chronic diseases.
[359] R. Wittes,et al. Methodologic guidelines for reports of clinical trials. , 1985, Cancer treatment reports.
[360] T. Lai. Incorporating scientific, ethical and economic considerations into the design of clinical trials in the pharmaceutical industry: a sequential approach , 1984 .
[361] J Cuzick,et al. A review of semi-parametric models for life histories. , 1984, IMA journal of mathematics applied in medicine and biology.
[362] David L. DeMets,et al. An overview of sequential methods and their application in clinical trials , 1984 .
[363] D. Anbar,et al. Stochastic approximation methods and their use in bioassay and phase i clinical trials , 1984 .
[364] David L. DeMets,et al. Stopping guidelines vs stopping rules: a practitioner's point of view , 1984 .
[365] Bernard Rosner,et al. Power and Sample Size for a Collection of 2 x 2 Tables , 1984 .
[366] R Simon,et al. A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias. , 1984, Statistics in medicine.
[367] J. Hokanson,et al. Comparing survival of responders and nonresponders after treatment: a potential source of confusion in interpreting cancer clinical trials. , 1983, Controlled clinical trials.
[368] J. van Eys,et al. Interaction between prognostic factors and treatment. , 1983, Controlled clinical trials.
[369] R W Makuch,et al. Sample size requirements for comparing time-to-failure among k treatment groups. , 1982, Journal of chronic diseases.
[370] A. Donner. The exclusion of patients from a clinical trial. , 1982, Statistics in medicine.
[371] K. K. Lan,et al. Stochastically curtailed tests in long–term clinical trials , 1982 .
[372] M Palta,et al. Magnitude and likelihood of loss resulting from non-stratified randomization. , 1982, Statistics in medicine.
[373] K McPherson,et al. On choosing the number of interim analyses in clinical trials. , 1982, Experientia. Supplementum.
[374] A Donner,et al. A Bayesian approach to the interpretation of subgroup results in clinical trials. , 1982, Journal of chronic diseases.
[375] R. Simon,et al. Nonparametric confidence limits for survival probabilities and median survival time. , 1982, Cancer treatment reports.
[376] L. Freedman. Tables of the number of patients required in clinical trials using the logrank test. , 1982, Statistics in medicine.
[377] C. Maxwell. Clinical trials, reviews, and the Journal of Negative Results. , 1981, British journal of clinical pharmacology.
[378] Rupert G. Miller,et al. Survival Analysis , 2022, The SAGE Encyclopedia of Research Design.
[379] M H Gail,et al. Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation. , 1981, Journal of chronic diseases.
[380] Robert F. Woolson,et al. Rank tests for censored matched pairs , 1980 .
[381] R W Makuch,et al. Sample size considerations for non-randomized comparative studies. , 1980, Journal of chronic diseases.
[382] David A. Schoenfeld,et al. Chi-squared goodness-of-fit tests for the proportional hazards regression model , 1980 .
[383] David L. DeMets,et al. Group sequential methods for clinical trials with a one-sided hypothesis , 1980 .
[384] D. V. Von Hoff,et al. The delta and epsilon errors in the assessment of cancer clinical trials. , 1979, Cancer treatment reports.
[385] Donald B. Rubin,et al. Bayesian Inference for Causal Effects: The Role of Randomization , 1978 .
[386] D. Barlow,et al. Single Case Experimental Designs: Strategies for Studying Behavior Change , 1976 .